Open Access, Rapid Publishing: No Longer a Thing of the Future
http://www.100md.com
《干细胞学杂志》
The new open-access policy from the National Institutes of Health has generated discussion across the research board. The STEM CELLS Website makes note of it, with links to two key government documents , as do many other peer-reviewed journal sites.
The spirit of open access is something STEM CELLS has fostered for some time. The journal already offers every published paper to all readers online after 1 year — the same time frame that the NIH policy specifies for submission of NIH-supported research articles that have been accepted to peer-reviewed journals. And coming soon there’s even better, faster news on the journal’s horizon: STEM CELLS EXPRESSTM.
With this new feature, STEM CELLS will present online—within 2 weeks of acceptance—all manuscripts accepted for publication as Rapid Communications. To be sure, these will not be copy-edited, final versions; but they will be searchable in Medline and citable, and they will be posted and accessible to subscribers far earlier than their corrected, edited, proofread versions . This feature will be in place before summer. We think that’s exciting.
"STEM CELLS will present online —within 2 weeks of acceptance— all manuscripts accepted for publication as Rapid Communications."
And beyond Rapid Communications, we plan to gradually expand the online "ahead-of-print" publication of accepted manuscripts to include every manuscript we accept.
Another advance comes in the form of Editorial Board development. We are honored to welcome the newest members of the STEM CELLS Board, who bring their creativity and dedication to serving the cause of cutting-edge research in this burgeoning field:
Edwin Horwitz
St. Jude Children’s Research Hospital
Linzhao Cheng
Johns Hopkins University School of Medicine
Ariff Bongso
National University of Singapore
Gerald de Haan
University of Groningen
Brian Sorrentino
St. Jude Children’s Research Hospital
STEM CELLS Editorial Board members serve key roles in the peer-review process. For each manuscript we review, there is a Board member leading the way. In welcoming new members, we expand the scope of the STEM CELLS lead reviewers as we expand their numbers, meeting the explosive increase we have seen in submitted manuscripts.
This brings us full-circle back to the spirit of open access. It is only through the rigorous application of peer review that the most groundbreaking research can serve its function of advancing the field. It is STEM CELLS, and its counterparts, performing the peer-review process that enables any of us who are engaged in the publishing of findings to realize the spirit of open access. We admire and thank all of the nearly 500 reviewers who have lent their expertise to STEM CELLS manuscript review work — as we’re sure the authors do as well.
A final note on a book that describes the ground-breaking work that has made stem cell research possible: Professor Donald Metcalf’s Blood Lines . New from AlphaMed Press, publisher of STEM CELLS, this volume will serve as an essential at-the-bench manual for every scientist exploring hematopoiesis or investigating stem cells. Visit http://www.BloodLines.StemCells.com for a link to more information on this historic explication by the father of hematopoietic cytokines.
REFERENCES
Policy on Enhancing Public Access to Archived Publications Resulting from NIH-Funded Research; Notice Number: NOT-OD-05-022. Available at http://grants.nih.gov/grants2/guide/notice-files/NOT-OD-05-022.html. Accessed March 10, 2005.
STEM CELLS EXPRESS. Available at http://stemcells.alphamedpress.org/misc/Stem_Cells_Express.pdf. Accessed March 10, 2005.
Metcalf D. Blood Lines: An Introduction to Characterizing Blood Diseases of the Post-Genomic Mouse. Durham, NC: AlphaMed Press (forthcoming).(Curt I. Civin, Editor-in-)
The spirit of open access is something STEM CELLS has fostered for some time. The journal already offers every published paper to all readers online after 1 year — the same time frame that the NIH policy specifies for submission of NIH-supported research articles that have been accepted to peer-reviewed journals. And coming soon there’s even better, faster news on the journal’s horizon: STEM CELLS EXPRESSTM.
With this new feature, STEM CELLS will present online—within 2 weeks of acceptance—all manuscripts accepted for publication as Rapid Communications. To be sure, these will not be copy-edited, final versions; but they will be searchable in Medline and citable, and they will be posted and accessible to subscribers far earlier than their corrected, edited, proofread versions . This feature will be in place before summer. We think that’s exciting.
"STEM CELLS will present online —within 2 weeks of acceptance— all manuscripts accepted for publication as Rapid Communications."
And beyond Rapid Communications, we plan to gradually expand the online "ahead-of-print" publication of accepted manuscripts to include every manuscript we accept.
Another advance comes in the form of Editorial Board development. We are honored to welcome the newest members of the STEM CELLS Board, who bring their creativity and dedication to serving the cause of cutting-edge research in this burgeoning field:
Edwin Horwitz
St. Jude Children’s Research Hospital
Linzhao Cheng
Johns Hopkins University School of Medicine
Ariff Bongso
National University of Singapore
Gerald de Haan
University of Groningen
Brian Sorrentino
St. Jude Children’s Research Hospital
STEM CELLS Editorial Board members serve key roles in the peer-review process. For each manuscript we review, there is a Board member leading the way. In welcoming new members, we expand the scope of the STEM CELLS lead reviewers as we expand their numbers, meeting the explosive increase we have seen in submitted manuscripts.
This brings us full-circle back to the spirit of open access. It is only through the rigorous application of peer review that the most groundbreaking research can serve its function of advancing the field. It is STEM CELLS, and its counterparts, performing the peer-review process that enables any of us who are engaged in the publishing of findings to realize the spirit of open access. We admire and thank all of the nearly 500 reviewers who have lent their expertise to STEM CELLS manuscript review work — as we’re sure the authors do as well.
A final note on a book that describes the ground-breaking work that has made stem cell research possible: Professor Donald Metcalf’s Blood Lines . New from AlphaMed Press, publisher of STEM CELLS, this volume will serve as an essential at-the-bench manual for every scientist exploring hematopoiesis or investigating stem cells. Visit http://www.BloodLines.StemCells.com for a link to more information on this historic explication by the father of hematopoietic cytokines.
REFERENCES
Policy on Enhancing Public Access to Archived Publications Resulting from NIH-Funded Research; Notice Number: NOT-OD-05-022. Available at http://grants.nih.gov/grants2/guide/notice-files/NOT-OD-05-022.html. Accessed March 10, 2005.
STEM CELLS EXPRESS. Available at http://stemcells.alphamedpress.org/misc/Stem_Cells_Express.pdf. Accessed March 10, 2005.
Metcalf D. Blood Lines: An Introduction to Characterizing Blood Diseases of the Post-Genomic Mouse. Durham, NC: AlphaMed Press (forthcoming).(Curt I. Civin, Editor-in-)